Thrilled to have been named the Singapore Cardiac Society lecturer this year (with my parents and family in the audience together for the first time!)… to God be the glory!

Congrats to Dr. Norman Stockbridge on receiving the Lifetime Achievement Award🏆

Dr. Stockbridge has made impressive contributions to the CV research & regulatory arena making a significant impact on the way clinical trials are conducted.
No one is more deserving of this award!

Another phenomenal British Society for Heart Failure #theFword MDT meeting in Glasgow. Lucky to count all these amazing folks as my colleagues and friends. BSH Nurse Forum Carys Barton 💙🫀#25in25 #Freedomfromfailure Edith Donnelly Claire McGrady Heart Failure Warriors NI

How exercise promotes a healthy immune response, reduces inflammation, and may slow the aging process
cell.com/cell-metabolis… Cell Metabolism P. Kent Langston

📍 #RCTs influence practice but validity can only be assessed if #reporting is transparent
📍We found that RCTs in high IF journals reported <70% req’d criteria
📍Key methods required to assess for bias were commonly underreported
doi.org/10.1002/ejhf.3…

MINOCA = 6-8% of all myocardial infarctions

Event rate following MINOCA about 10%/year: not lower than after ACS with coronary obstruction

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 on #ESCTVToday with lots of further insight

watch: esc365.escardio.org/event/1149 (starting 05:30).

European Society of Cardiology #Cardiotwitter

On monitoring for progression of CKD based upon GFR and ACR categories from KDIGO #Nephpearls

👉 kdigo.org/guidelines/ckd…

Delighted our paper on strategies to deliver sex-based equity in CV clinical trials is now published in Nature Reviews Cardiology
nature.com/articles/s4156…

Charles Knight OBE 🇺🇦 SCTS UK SCTS WiCTS ACNAPPresident BCS President CSANZ European Society of Cardiology William Harvey Research Institute Enoch Akowuah Prof Calvin Moorley RN PhD Dr Simon Woldman

On empty, redundant or pointless systematic reviews onlinelibrary.wiley.com/doi/epdf/10.11…

Wow some important facts on #globisty The slides just sums it up. #world #crisis 📈 #cardiovascular #risk #ESCPrev2024 congress Vass Vassiliou Dr Anastasia Mihailidou FAHA FCSANZ FESC Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Original Article: Empagliflozin after Acute Myocardial Infarction (EMPACT-MI) nej.md/4cEb6EB

Editorial: Decreasing the Risk of Heart Failure in a Changing Post–Myocardial Infarction Environment nej.md/3vFF1LK

Of 35 patients with transfusion-dependent β-thalassemia treated with gene-edited autologous hematopoietic stem and progenitor cells, 32 had hemoglobin levels maintained without red-cell transfusions for at least 12 consecutive months. Full study results: nej.md/3xYXrI1

By the time I see INOCA patients in my clinic, they have gone to numerous healthcare professionals, had numerous tests and most of them have been told there's not a problem with their heart...

Watch the video presentation on cardiac rehab and INOCA here -
inocainternational.com/video-presenta…

BBI congrats @katherinetuttl8 for her new theoretical framework for potential approaches to implementing 4 pillars of guideline-directed medical therapy for type 2 diabetes & CKD. Paper published in Circulation
Brigham and Women's Hospital Harvard Medical School UNSW
ahajournals.org/doi/10.1161/CI…

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians

ACP

How have HF mortality rates changed from 1999-2021 in the US❓

From 1999-2012📉: Decline by ~25%
From 2012-2021📈: Reversals that have now undone ALL initial declines.

Result: HF mortality in 2021 > HF mortality in 1999 ‼️

Link to our work JAMA Cardiology : jamanetwork.com/journals/jamac…

🎉 20 years celebrations! 🎉

I look back with pride and a real sense of achievement as the #HFA_ESC has grown from a group of enthusiasts to a large respected scientific community influencing the field of #heartfailure .

It's all thanks to YOU!

Celebrate with us: comment, share…

New work in #JACCHF on the treatment effects of ICDs for patients w/ chronic #HFrEF — baseline frailty status significantly modifies risk of all-cause mortality in this large cohort from SCD-HeFT bit.ly/49M6g5v

#epICD #HeartFailure Matt Segar Neil Keshvani ambarish

In Episode 9 of our Understanding INOCA series, we welcome INOCA International Medical Advisory Board member, Sister Ashley Davidson discussing Cardiac Rehab and INOCA! 😃

You can enjoy the full video presentation here -
inocainternational.com/video-presenta…

.JACC Journals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️

jacc.org/doi/10.1016/j.…